Biomarker Enhanced Risk Prediction for Adverse Outcomes in Critically Ill Patients Receiving RRT
Open Access
- 1 August 2015
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Clinical Journal of the American Society of Nephrology
- Vol. 10 (8), 1332-1339
- https://doi.org/10.2215/cjn.09911014
Abstract
Background and objectives Higher plasma concentrations of inflammatory and apoptosis markers in critically ill patients receiving RRT are associated with RRT dependence and death. This study objective was to examine whether plasma inflammatory (IL-6, -8, -10, and -18; macrophage migration inhibitory factor) and apoptosis (death receptor-5, tumor necrosis factor receptor I and II) biomarkers augment risk prediction of renal recovery and mortality compared with clinical models. Design, setting, participants, & measurements The Biologic Markers of Recovery for the Kidney study (n=817) was a prospective, nested, observational cohort study conducted as an ancillary to the Veterans Affairs/National Institutes of Health Acute renal failure Trial Network study, a randomized trial of intensive versus less intensive RRT in critically ill patients with AKI conducted between November 2003 and July 2007 at 27 Veterans Affairs– and university-affiliated centers. Primary outcomes of interest were renal recovery and mortality at day 60. Results A parsimonious clinical model consisting of only four variables (age, mean arterial pressure, mechanical ventilation, and bilirubin) predicted renal recovery (area under the receiver-operating characteristic curve [AUROC], 0.73; 95% confidence interval [95% CI], 0.68 to 0.78) and mortality (AUROC, 0.74; 95% CI, 0.69 to 0.78). By contrast, individual biomarkers were only modestly predictive of renal recovery (AUROC range, 0.55–0.63) and mortality (AUROC range, 0.54–0.68). Adding plasma IL-8 to a parsimonious model augmented prediction of recovery (AUROC, 0.76; 95% CI, 0.71 to 0.81; P=0.04) and mortality (AUROC, 0.78; 95% CI, 0.73 to 0.82; PConclusions This study suggests that a simple four-variable clinical model with plasma IL-8 had predictive value for renal recovery and mortality. These findings require external validation but could easily be used by clinicians.This publication has 18 references indexed in Scilit:
- Validation of Cell-Cycle Arrest Biomarkers for Acute Kidney Injury Using Clinical AdjudicationAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Discovery and validation of cell cycle arrest biomarkers in human acute kidney injuryCritical Care, 2013
- Model to Predict Mortality in Critically Ill Adults with Acute Kidney InjuryClinical Journal of the American Society of Nephrology, 2011
- Urinary Biomarkers and Renal Recovery in Critically Ill Patients with Renal SupportClinical Journal of the American Society of Nephrology, 2011
- Improved performance of urinary biomarkers of acute kidney injury in the critically ill by stratification for injury duration and baseline renal functionKidney International, 2011
- Intensity of Renal Support in Critically Ill Patients with Acute Kidney InjuryThe New England Journal of Medicine, 2008
- Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyondStatistics in Medicine, 2007
- A new method of classifying prognostic comorbidity in longitudinal studies: Development and validationJournal of Chronic Diseases, 1987
- APACHE II-A Severity of Disease Classification SystemCritical Care Medicine, 1986
- APACHE IICritical Care Medicine, 1985